Thrombocytosis is present in more than 30% of patients with solid malignancies and
correlates with worsened patient survival. Tumor cell interaction with various cellular …

Ovarian high-grade serous carcinoma (HGSC) results in the highest mortality among
gynecological cancers, developing rapidly and aggressively. Dissimilarly, serous borderline …

The diversity and heterogeneity within high-grade serous ovarian cancer (HGSC), which is
the most lethal gynecologic malignancy, is not well understood. Here, we perform …

Importance Survivorship involves a multidisciplinary approach to surveillance and
management of comorbidities and secondary cancers, overseen by oncologists, surgeons …

Anti-angiogenesis therapy has shown clinical benefit in patients with high-grade serous
ovarian cancer (HGSC), but adaptive resistance rapidly emerges. Thus, approaches to …

Background Homologous recombination deficiency (HRD) score is related to chemotherapy
response in some cancers, but its role in endometrial cancer in not known. We determined …

Adrenergic signaling is known to promote tumor growth and metastasis, but the effects on
tumor stroma are not well understood. An unbiased bioinformatics approach analyzing …

OBJECTIVE: To evaluate the association between prophylactic ureteral stent placement at
the time of hysterectomy for placenta accreta spectrum and genitourinary injury. METHODS …

Abstract Study Objective To investigate whether endometrial ablation is associated with
increased risk or delayed diagnosis of endometrial cancer compared with medical …

Objective Although experimental models suggest that use of beta-blockers, a common
antihypertensive agent, may improve survival in ovarian cancer patients, results from clinical …